Original Source(s)
Related Content
Oral Aleniglipron Reduced Weight at 36 Weeks
In a phase 2b trial, the highest dose produced an estimated 12% mean weight reduction vs 1% with placebo, although gastrointestinal adverse events were common.
July 16, 2026
-
6 min
Synthetic Echo Motion May Aid ECG Risk Modeling
An ensemble electrocardiogram model classified derived diastolic dysfunction risk phenotypes and stratified heart failure–related death risk across external cohorts, according to findings presented at ASE 2026.
by Kerri Miller
June 27, 2026
-
3 min
Serostatus May Modify RA Activity–CV Link
Combined rheumatoid factor and anticitrullinated protein antibody status appeared to modify the association between baseline rheumatoid arthritis disease activity and subsequent cardiovascular events in an international observational cohort.
July 15, 2026
-
4 min